Small Cell Neuroendocrine Carcinoma — Trials

Small Cell Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,165 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 396
Recruiting: 209
Ph III recruiting: 27
Growth YoY: +1%
Industry share: 42%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04507919	Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer	no longer available	—	—	Novartis PharmaceuticalsINDUSTRY	0	Nov 12, 2024	clinicaltrials
NCT03503890	Expanded Access to Rovalpituzumab Tesirine	no longer available	—	—	AbbVieINDUSTRY	0	Sep 10, 2019